{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:54:38Z","timestamp":1790128478390,"version":"4.0.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2009,2,18]],"date-time":"2009-02-18T00:00:00Z","timestamp":1234915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004517","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T23:53:19Z","timestamp":1234914799000},"page":"e4517","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Is Antiretroviral Therapy Causing Long-Term Liver Damage? A Comparative Analysis of HIV-Mono-Infected and HIV\/Hepatitis C Co-Infected Cohorts"],"prefix":"10.1371","volume":"4","author":[{"given":"Erica E. M.","family":"Moodie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Pant Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina B.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,2,18]]},"reference":[{"key":"ref1","first-page":"659","article-title":"Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.","volume":"160","author":"RS Hogg","year":"1999","journal-title":"Cmaj"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"FJ Palella Jr","year":"1998","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.","volume":"32","author":"I Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10096-002-0823-0","article-title":"Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.","volume":"21","author":"J Macias","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref5","first-page":"Abstract 572","article-title":"Liver-related mortality in human immunodeficiency virus-infected patients in France (GERMIVIC cohort study, 1995\u20132003);","author":"E Rosenthal"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","article-title":"Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.","volume":"42","author":"D Salmon-Ceron","year":"2005","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00126334-200204010-00009","article-title":"Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987\u20131999.","volume":"29","author":"RM Selik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000077549","article-title":"Increasing incidence of critical liver disease among causes of death in Japanese hemophiliacs with HIV-1.","volume":"111","author":"S Tatsunami","year":"2004","journal-title":"Acta Haematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1086\/514987","article-title":"Rapidly evolving hepatitis C virus-related cirrhosis in a human immunodeficiency virus-infected patient receiving triple antiretroviral therapy.","volume":"27","author":"H Zylberberg","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref10","article-title":"HIV\/AIDS Epi Updates.","year":"2005"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.","volume":"33","author":"CS Graham","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF01691375","article-title":"Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C.","volume":"14","author":"A Sanchez-Quijano","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.","volume":"26","author":"B Soto","year":"1997","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","article-title":"Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.","volume":"19","author":"MS Sulkowski","year":"2005","journal-title":"Aids"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/jhep.2001.26517","article-title":"Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.","volume":"34","author":"Y Benhamou","year":"2001","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200403260-00007","article-title":"Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine.","volume":"18","author":"J Macias","year":"2004","journal-title":"Aids"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/00002030-200411050-00008","article-title":"Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV\/hepatitis C virus co-infected patients.","volume":"18","author":"E Marine-Barjoan","year":"2004","journal-title":"Aids"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/aid.2004.20.1293","article-title":"Advanced liver fibrosis in HIV\/HCV-coinfected patients on antiretroviral therapy.","volume":"20","author":"D Fuster","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.20541","article-title":"The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.","volume":"41","author":"SH Mehta","year":"2005","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1468-1293.2005.00330.x","article-title":"Validation of a simple model for predicting liver fibrosis in HIV\/hepatitis C virus-coinfected patients.","volume":"6","author":"H Al-Mohri","year":"2005","journal-title":"HIV Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.qai.0000184856.31695.bf","article-title":"HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.","volume":"40","author":"D Nunes","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2005.02.025","article-title":"Prediction of hepatic fibrosis in HIV\/HCV co-infected patients using serum fibrosis markers: the SHASTA index.","volume":"43","author":"TB Kelleher","year":"2005","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0b013e318030ff8e","article-title":"Evaluating Liver Fibrosis Progression and the Impact of Antiretroviral Therapy in HIV and Hepatitis C Coinfection Using a Noninvasive Marker.","volume":"44","author":"H Al-Mohri","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/JCM.38.11.4034-4041.2000","article-title":"Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.","volume":"38","author":"DG Murphy","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"CT Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1002\/0470090456.ch7","article-title":"The Propensity Score with Continuous Treatments.","author":"K Hirano","year":"2004"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/biomet\/87.3.706","article-title":"The role of the propensity score in estimating dose-response functions.","volume":"87","author":"GW Imbens","year":"2000","journal-title":"Biometrika"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1196\/annals.1299.047","article-title":"Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo.","volume":"1010","author":"H Yasui","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations.","volume":"26","author":"GEP Box","year":"1964","journal-title":"Journal of the Royal Statistical Society Series B"},{"key":"ref30","article-title":"Causal Inference from Complex Longitudinal Data. Latent Variable Modeling and Applications to Causality","author":"J Robins","year":"1997"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"JM Robins","year":"2000","journal-title":"Epidemiology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.","volume":"1","author":"B Maharaj","year":"1986","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C.","volume":"38","author":"P Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"ref34","first-page":"Abstract 161","article-title":"Staging liver disease in HIV\/HCV co-infected persons: is liver biopsy the right test?;","author":"D Thomas"},{"key":"ref35","article-title":"Can routine non-invasive tests predict liver histology in HIV\/HCV co-infection?","author":"R Sterling"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.","volume":"357","author":"F Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.","volume":"36","author":"X Forns","year":"2002","journal-title":"Hepatology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:46:33Z","timestamp":1738957593000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004517"}},"subtitle":[],"editor":[{"given":"Srikanth","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,2,18]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004517","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,18]]}}}